EarningsQ2 2024 Earnings Report

Filana Therapeutics (FLNA) Q2 2024 Earnings Report

0 Followers

MX:FLNA Q2 2024 EPS Results

Actual EPS$2.25

Consensus EPS-$7.04

Beat/MissBeat by +$9.29

One Year Ago EPS-$10.90

Actual Revenue$0.00

Expected Revenue$0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ2 2024

Date08/08/2024

TimeBefore Open

Conference CallThursday, August 8, 2024

MX:FLNA Q2 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Aug 05, 2026	2026 (Q2)	-3.89 / -3.12	-15.924	80.43% (+12.81)
May 07, 2026	2026 (Q1)	-3.98 / -3.63	-8.308	56.25% (+4.67)
Mar 12, 2026	2025 (Q4)	-5.19 / -4.50	-9.866	54.39% (+5.37)
Nov 12, 2025	2025 (Q3)	-4.67 / -3.81	-10.039	62.07% (+6.23)
Aug 14, 2025	2025 (Q2)	- / -15.92	2.25	-807.69% (-18.17)
May 08, 2025	2025 (Q1)	- / -8.31	-7.443	-11.63% (-0.87)
Mar 03, 2025	2024 (Q4)	-10.09 / -9.87	-8.654	-14.00% (-1.21)
Nov 07, 2024	2024 (Q3)	-12.64 / -10.04	-10.558	4.92% (+0.52)
Aug 08, 2024	2024 (Q2)	-7.04 / 2.25	-10.905	120.63% (+13.15)
May 10, 2024	2024 (Q1)	-7.96 / -7.44	-10.039	25.86% (+2.60)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed